Literature DB >> 21168812

A reappraisal of eyelid eccrine and apocrine hidrocystomas: microanatomic and immunohistochemical studies of 40 lesions.

Frederick A Jakobiec1, Fouad R Zakka.   

Abstract

PURPOSE: To establish reliable criteria for diagnosing eyelid eccrine and apocrine hidrocystomas.
DESIGN: Retrospective clinicopathologic and immunohistochemical study.
METHODS: Twenty-two specimens of normal portions of eyelids were evaluated to establish the distribution and microanatomy of eccrine and apocrine glands. Immunostaining for cytokeratin 7 (CK7), gross cystic disease fluid protein-15 (GCDFP-15), alpha-smooth muscle actin (α-SMA), epithelial membrane antigen (EMA), and carcinoembryonic antigen (CEA) was performed on these tissues and on 40 lesions in 33 patients diagnosed with eccrine or apocrine hidrocystomas by unaided light microscopy.
RESULTS: Eccrine glands were not present in the eyelid margins, the lower half of the upper eyelid pretarsal skin, or the pretarsal lower eyelid skin. Apocrine glands were restricted to the eyelid margins and canthi where the cysts were located. GCDFP-15, CK7, and α-SMA immunoreacted with the eccrine secretory coils but not their ducts; apocrine gland secretory spirals also stained positively for these markers throughout their extended courses, but not their short terminal ducts. Positivity was found in 37 of 40 hidrocystomas for α-SMA and 19 for GCDFP-15; lesions tested for CK7 displayed positivity.
CONCLUSIONS: Alpha-SMA-, CK7-, and/or GCDFP-15-positive apocrine hidrocystomas were the only type discovered in this series and arose from glandular secretory spirals within the marginal, perimarginal, or canthal skin. Three lesions did not stain for α-SMA, initially suggesting an absent myoepithelium and therefore an eccrine ductal origin; they manifested CK7 positivity, however, another characteristic of the apocrine secretory spiral but not ducts. Our findings disprove the contention that eccrine predominate over apocrine hidrocystomas in the eyelids.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168812     DOI: 10.1016/j.ajo.2010.08.028

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Pleomorphic basal cell carcinoma of the eyelid with true ductular differentiation.

Authors:  Frederick A Jakobiec; Fouad R Zakka; Daniel J Townsend
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-26       Impact factor: 3.117

Review 2.  Apocrine hidrocystoma of the lower lip: a case report and literature review.

Authors:  Kentaro Kikuchi; Shuichi Fukunaga; Harumi Inoue; Yuji Miyazaki; Fumio Ide; Kaoru Kusama
Journal:  Head Neck Pathol       Date:  2013-06-06

3.  Ectopic Tubular Papillary Apocrine Adenoma on the Eyelid: A Case Report of Misleading Clinical Presentation and Location.

Authors:  Laura Abbeel; Rita Van Ginderdeuren
Journal:  Ocul Oncol Pathol       Date:  2018-02-06

4.  Histological study of eyelid hidrocystoma: A clinical case.

Authors:  Sofia Karachrysafi; Georgios Fadel; Viktoria Kapourani; Fani Akritidou; Pinelopi Anastasiadou; Theodora Papamitsou; Antonia Sioga; Elie Fadel
Journal:  SAGE Open Med Case Rep       Date:  2022-05-11

5.  Fine-needle aspiration cytology of eccrine hidrocystoma.

Authors:  Shelly Sehgal; Reena Agarwal; Sompal Singh; Prashant Goyal
Journal:  Cytojournal       Date:  2012-02-24       Impact factor: 2.091

6.  What could this dark lesion on a woman's eyelid be?

Authors:  Maria Victoria Rosso; Maria Victoria Rodriguez Kowalczuk; Maria Manuela Martinez Piva; Luis Daniel Mazzuoccolo
Journal:  Int J Womens Dermatol       Date:  2022-08-24

Review 7.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

8.  Three Adult Cases of Orbital Hidrocystoma Presenting with Blepharoptosis.

Authors:  Lucieni B Ferraz; John R Burroughs; Larissa H Satto; Kryscia L Natsuaki; Roberta L F S Meneguin; Mariangela E A Marques; Silvana A Schellini
Journal:  J Clin Med       Date:  2015-01-13       Impact factor: 4.241

Review 9.  Pathology of eyelid tumors.

Authors:  Jacob Pe'er
Journal:  Indian J Ophthalmol       Date:  2016-03       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.